Mingwei Fei

1.7k total citations
20 papers, 354 citations indexed

About

Mingwei Fei is a scholar working on Hematology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mingwei Fei has authored 20 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Oncology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mingwei Fei's work include Hematopoietic Stem Cell Transplantation (12 papers), Multiple Myeloma Research and Treatments (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Mingwei Fei is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Multiple Myeloma Research and Treatments (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Mingwei Fei collaborates with scholars based in United States, Australia and United Kingdom. Mingwei Fei's co-authors include Mary M. Horowitz, Raju Khatiwada, David Mengel, Ganga M. Hettiarachchi, Brent R. Logan, Steven M. Devine, Stephanie J. Lee, Nancy L. Geller, Marcelo C. Pasquini and Sergio Giralt and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Mingwei Fei

20 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingwei Fei United States	11	264	134	88	59	58	20	354
E. F. Winton United States	9	145 0.5×	81 0.6×	103 1.2×	9 0.2×	51 0.9×	14	481
Ansu Abu Alex India	9	202 0.8×	68 0.5×	150 1.7×	35 0.6×	94 1.6×	22	334
Moazzam Shahzad United States	10	123 0.5×	175 1.3×	58 0.7×	18 0.3×	29 0.5×	85	347
Joseph A. Pidala United States	8	196 0.7×	56 0.4×	22 0.3×	42 0.7×	82 1.4×	46	309
Sanjeevan Sharma India	11	216 0.8×	59 0.4×	96 1.1×	23 0.4×	32 0.6×	53	306
Saroj Singh India	12	93 0.4×	56 0.4×	66 0.8×	118 2.0×	134 2.3×	61	553
Campbell Tiley Australia	10	216 0.8×	159 1.2×	78 0.9×	39 0.7×	40 0.7×	25	351
Sudha Sazawal India	12	309 1.2×	94 0.7×	366 4.2×	76 1.3×	191 3.3×	55	811
Kirk Morris Australia	8	84 0.3×	77 0.6×	34 0.4×	24 0.4×	39 0.7×	33	255
Asmâa Quessar Morocco	9	73 0.3×	65 0.5×	49 0.6×	34 0.6×	39 0.7×	50	244

Countries citing papers authored by Mingwei Fei

Since Specialization

Citations

This map shows the geographic impact of Mingwei Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingwei Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingwei Fei more than expected).

Fields of papers citing papers by Mingwei Fei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingwei Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingwei Fei. The network helps show where Mingwei Fei may publish in the future.

Co-authorship network of co-authors of Mingwei Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Mingwei Fei. A scholar is included among the top collaborators of Mingwei Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingwei Fei. Mingwei Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Logan, Brent R., Alan Howard, Mingwei Fei, et al.. (2023). Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death. Journal of Clinical Investigation. 133(15). 5 indexed citations

Ranch, Daniel, et al.. (2023). Utilization of donor‐derived Cell‐Free DNA in pediatric kidney transplant recipients: A single center study. Pediatric Transplantation. 28(1). e14582–e14582. 5 indexed citations

Hamadani, Mehdi, Mei-Jie Zhang, Mingwei Fei, et al.. (2020). Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis. Biology of Blood and Marrow Transplantation. 26(7). 1312–1317. 43 indexed citations

Hari, Parameswaran, Marcelo C. Pasquini, Edward A. Stadtmauer, et al.. (2020). Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM).. Journal of Clinical Oncology. 38(15_suppl). 8506–8506. 60 indexed citations

Giralt, Sergio, Luciano J. Costa, David G. Maloney, et al.. (2019). Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial. Biology of Blood and Marrow Transplantation. 26(4). 798–804. 29 indexed citations

Waller, Edmund K., Brent R. Logan, Mingwei Fei, et al.. (2019). Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF–mobilized stem cell transplantation. Blood Advances. 3(15). 2250–2263. 31 indexed citations

Harris, Andrew C., Jaap Jan Boelens, Kwang Woo Ahn, et al.. (2018). Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine. Blood Advances. 2(11). 1198–1206. 17 indexed citations

Eapen, Mary, Joanne Kurtzberg, Mei-Jie Zhang, et al.. (2017). Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes. Biology of Blood and Marrow Transplantation. 23(10). 1714–1721. 18 indexed citations

Knight, Jennifer M., Karen L. Syrjala, Navneet S. Majhail, et al.. (2016). Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. Biology of Blood and Marrow Transplantation. 22(12). 2256–2263. 17 indexed citations

10.

Eapen, Mary, Joanne Kurtzberg, Mei‐Jie Zhang, et al.. (2016). Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes. Blood. 128(22). 1231–1231. 1 indexed citations

11.

Mahindra, Anuj, Raphael Fraser, Mingwei Fei, et al.. (2016). Patients (pts) with Renal Insufficiency (RI) and Multiple Myeloma (MM) Have Similar Outcomes after Autologous Hematopoietic Cell Transplantation (AHCT) As Those without. Blood. 128(22). 994–994. 3 indexed citations

12.

D’Souza, Anita, Jiaxing Huang, Mingwei Fei, & Parameswaran Hari. (2016). Trends in Pre- and Post-Transplant Therapies Prior to First Autologous Hematopoietic Cell Transplantation Among Patients with Multiple Myeloma in the United States, 2004-2014. Blood. 128(22). 677–677. 2 indexed citations

13.

Harris, Andrew C., Jaap Jan Boelens, Kwang Woo Ahn, et al.. (2016). Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children. Blood. 128(22). 664–664. 1 indexed citations

14.

Htut, Myo, Anita D’Souza, Benedetto Bruno, et al.. (2016). Survival after Relapse Following Tandem Allogeneic Vs. Tandem Autologous Hematopoietic Cell Transplantation (HCT) for Myeloma (MM). Blood. 128(22). 833–833. 1 indexed citations

15.

Wood, William A., Jennifer Le‐Rademacher, Karen L. Syrjala, et al.. (2015). Patient‐reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). Cancer. 122(1). 91–98. 49 indexed citations

16.

Khatiwada, Raju, Ganga M. Hettiarachchi, David Mengel, & Mingwei Fei. (2014). Placement and Source Effects of Phosphate Fertilizers on Phosphorus Availability and Reaction Products in Two Reduced-Till Soils. Soil Science. 179(3). 141–152. 11 indexed citations

17.

Barker, Juliet N., Mingwei Fei, Chatchada Karanes, et al.. (2014). Results of a prospective multicentre myeloablative double‐unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia. British Journal of Haematology. 168(3). 405–412. 24 indexed citations

18.

Wood, William A., Jennifer Le‐Rademacher, Mingwei Fei, et al.. (2014). Patient-Reported Quality of Life Is an Independent Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation: A Secondary Analysis from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. Blood. 124(21). 206–206. 9 indexed citations

19.

Fei, Mingwei. (2012). A STUDY OF THE ROBUSTNESS OF COX'S PROPORTIONAL HAZARDS MODEL USED IN TESTING FOR COVARIATE EFFECTS. K-State Research Exchange (Kansas State University). 1 indexed citations

20.

Khatiwada, Raju, Ganga M. Hettiarachchi, David Mengel, & Mingwei Fei. (2012). Speciation of Phosphorus in a Fertilized, Reduced‐Till Soil System: In‐Field Treatment Incubation Study. Soil Science Society of America Journal. 76(6). 2006–2018. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact